newsfilter
← Latest News
GlobeNewswire·

GeoVax COVID-19 Vaccine Clinical Data Presented at World Vaccine Congress

Presentation of Data from Phase 2 Open-Label Study of GEO-CM04S1 Next-Generation COVID-19 Vaccine Demonstrates Potent Antibody and Cellular Immunity in Immunocompromised Patients ATLANTA, GA, Nov. 28, 2023